World Drug Safety Congress Americas 2025 focuses on drug safety, pharmacovigilance and patient safety management, spanning the full safety lifecycle from early-stage safety assessment to post-market monitoring.

The event brings together pharmaceutical safety teams, CROs, technology vendors, regulators and risk management specialists for conference content, exhibition activity and meetings around AI/ML pharmacovigilance, real-world evidence, patient-centric safety strategies and regulatory compliance.

The 2025 edition took place at the Boston Convention & Exhibition Center, drawing 1,300 professionals from the global drug safety industry.